- In the
early fetus,
erythropoiesis takes place in the
mesodermal cells of the yolk sac. By the
third or
fourth month,
erythropoiesis moves to the liver...
-
Erythropoiesis".
Advances in Hematology. 2010: e358283. doi:10.1155/2010/358283. ISSN 1687-9104. Rivella,
Stefano (2013). "Ineffective
erythropoiesis...
-
Erythropoiesis-stimulating
agents (ESA) are
medications which stimulate the bone
marrow to make red
blood cells. They are used to
treat anemia due to end...
-
Latent iron
deficiency (LID), also
called iron-deficient
erythropoiesis, is a
medical condition in
which there is
evidence of iron
deficiency without anemia...
-
response to
cellular hypoxia; it
stimulates red
blood cell
production (
erythropoiesis) in the bone marrow. Low
levels of EPO (around 10 mU/mL) are constantly...
-
recommendations may also
apply to some
people with
acute bleeding.
Erythropoiesis-stimulating
agents are only
recommended in
those with
severe anemia...
- are reduced.
Other mechanisms may also play a role, such as
reduced erythropoiesis. It is also
known as
anemia of inflammation, or
anemia of inflammatory...
-
recombinant DNA technology.
Epoetin alfa is an
erythropoiesis-stimulating agent. It
stimulates erythropoiesis (increasing red
blood cell levels) and is used...
- half-life
compared to
epoetin alpha and
epoetin beta. It
stimulates erythropoiesis (increases red
blood cell levels) by the same
mechanism as
rHuEpo (binding...
-
processes in the
human body,
including lung development,
embryonic erythropoiesis,
epithelial integrity, T-cell viability, and adipogenesis. Erythroid...
